Media Coverage Year None20242023 Traditional gene therapies are uber-niche. Ocugen hopes to change that. August 15, 2024 Evidence mounts that future vaccines should be inhaled December 25, 2023 Ocugen Clinical Trial Could Lead to Breakthrough One-Time Treatment for Advanced Dry Macular Degeneration December 19, 2023 Up the Nose and Down the Windpipe May Be the Path to New and Improved COVID-19 Vaccines December 6, 2023 The Eye: A Candidate For Modifier Gene Therapy November 17, 2023 Study Highlights Standout Clinical Success of Certain Cell and Gene Therapies November 6, 2023 U.S. Vaccine Program Now Flush With Cash, but Short on Key Details June 26, 2023 Podcasts Year None20242023 Modifier gene therapy for ocular diseases - Podcast (europeanpharmaceuticalreview.com) April 30, 2024 Dr. Shankar Musunuri, Chairman, CEO And Co-Founder Ocugen December 13, 2023 Building A Better COVID Vaccine With Ocugen's Shankar Musunuri, Ph.D. October 3, 2023 Eyepod: Ocugen CEO gives update on OCU400 October 2, 2023
Ocugen Clinical Trial Could Lead to Breakthrough One-Time Treatment for Advanced Dry Macular Degeneration December 19, 2023
Up the Nose and Down the Windpipe May Be the Path to New and Improved COVID-19 Vaccines December 6, 2023
Modifier gene therapy for ocular diseases - Podcast (europeanpharmaceuticalreview.com) April 30, 2024
